siRNA treatment lowers triglycerides in patients along with unusual health condition
.INVESTIGATION FEATURE.19 September 2024.
Plozasiran reduced triglyceride degrees through 80% and decreased the danger of pancreatitis in individuals along with consistent chylomicronemia, with or without a genetic prognosis.